Annexon (ANNX) Total Current Liabilities (2019 - 2026)

Annexon's (ANNX) quarterly Total Current Liabilities came in at $35.9 million in Q1 2026, up 7.12% year-on-year from $33.5 million in Q1 2025, and down 15.7% quarter-over-quarter from $42.6 million in Q4 2025.

Annexon (ANNX) Total Current Liabilities (2019 - 2026) Analysis & Trends

Annexon's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $35.9 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 7.12% year-over-year to $35.9 million in Q1 2026; TTM through Mar 2026 was $35.9 million, a 7.12% increase from a year earlier, with the FY2025 full-year figure at $42.6 million, up 39.72% from the prior year.
  • Total Current Liabilities declined to $35.9 million in Q1 2026 per ANNX's latest filing, from $42.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $43.6 million in Q3 2025 and bottomed at $13.1 million in Q1 2024.
  • The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $25.5 million.
  • Across the five-year window, Total Current Liabilities slumped 42.75% in 2024 and soared 155.44% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $22.4 million in 2022, then retreated by 19.82% to $17.9 million in 2023, then surged by 70.19% to $30.5 million in 2024, then soared by 39.72% to $42.6 million in 2025, then declined by 15.7% to $35.9 million in 2026.
  • Per Business Quant, the three latest ANNX Total Current Liabilities figures stand at $35.9 million (Q1 2026), $42.6 million (Q4 2025), and $43.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Annexon 1.03 Bn 804.24 Mn - 35.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.94 Mn
Dec 31, 2025 42.63 Mn
Sep 30, 2025 43.58 Mn
Jun 30, 2025 40.64 Mn
Mar 31, 2025 33.55 Mn
Dec 31, 2024 30.51 Mn
Sep 30, 2024 20.05 Mn
Jun 30, 2024 17.15 Mn
Mar 31, 2024 13.13 Mn
Dec 31, 2023 17.93 Mn
Sep 30, 2023 17.17 Mn
Jun 30, 2023 17.89 Mn
Mar 31, 2023 22.94 Mn
Dec 31, 2022 22.36 Mn
Sep 30, 2022 20.22 Mn
Jun 30, 2022 20.25 Mn
Mar 31, 2022 17.05 Mn
Dec 31, 2021 21.74 Mn
Sep 30, 2021 11.92 Mn
Jun 30, 2021 10.28 Mn